Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03766256 · ClinicalTrials.gov registry record · NA
Shared Decision Making in Diabetes Prevention for Women With a History of GDM
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT03766256 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 33 participants.
The verdict
NCT03766256, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
Gestational diabetes mellitus (GDM) is a risk factor for the development of Type 2 diabetes. Lifestyle change and metformin are equally effective in preventing diabetes in patients with a history of GDM, so these women should choose a strategy based on their preferences and values, which may vary by race/ethnicity. This proposal will engage 32 women in shared decision making about diabetes prevention.
Interventions
- BEHAVIORAL Shared decision-making with pharmacists
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2019-03-01 |
| Est. Completion | 2019-12-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03766256
The ClinicalTrials.gov registry entry for NCT03766256 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Shared decision-making with pharmacists is the first listed.
NCT03766256 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03766256 about?
NCT03766256 is a clinical study titled "Shared Decision Making in Diabetes Prevention for Women With a History of GDM". Gestational diabetes mellitus (GDM) is a risk factor for the development of Type 2 diabetes. Lifestyle change and metformin are equally effective in preventing diabetes in patients with a history of GDM, so these women should choose a strategy based on their preferences and values, which may vary by...
What is the current status of trial NCT03766256?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2019-03-01. Estimated completion is 2019-12-28.
What interventions are being tested in trial NCT03766256?
The interventions under investigation include: Shared decision-making with pharmacists (BEHAVIORAL).
Who is sponsoring clinical trial NCT03766256?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.